Published in Gene Therapy Weekly, September 27th, 1999
G.L. Clayman and colleagues from the University of Texas M.D. Anderson Cancer Center investigated therapeutic options to improve the survival rate for patients with head and neck cancer. Their study was reported in the journal Clinical Cancer Research ("Adenovirus-Mediated Wild-Type p53 Gene Transfer as a Surgical Adjuvant in Advanced Head and Neck Cancers," Clinical Cancer Research, July 1999;5(7):1715-1722).
"A high incidence of locoregional failure contributes to the poor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.